FDA Center for Drug Evaluation and Research develops strategic science and research agenda
A U.S. Food and Drug Administration report from its Center for Drug Evaluation and Research (CDER), available today in the Federal Register, identifies the current regulatory science needs that will guide CDER s strategic planning of internal research initiatives and contributions to the development of agency regulatory science efforts.